Q4 2024 Management View CEO Panna Sharma highlighted 2024 as a transformational year, emphasizing the company's advancements in computational and AI-driven drug discovery, particularly in precision ...

Lipocine has announced the commencement of a Phase III clinical trial of LPCN 1154, being developed for postpartum depression ...

Through this partnership, NeOnc will initiate clinical trials across 30 FDA-compliant clinical research sites in India, increasing patient enrollment and accelerating development efforts for a novel ...

New sites for field trials of a UQ strategy to combat Phalaris are needed in southern Qld and northern NSW...Read More ...

The University of Manitoba has launched a new unit—the Academic Contract Research Organization (aCRO)—with the goal of strengthening the province’s capacity for human clinical trials. The aCRO is ...

Q4 2024 Management View CEO Josh Riggs highlighted significant progress in advancing OncoCyte's clinical assay, including the launch of GraftAssure, a research-use-only kidney transplant test. The ...

Icon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the first CRO to completely integrate this technology into its workflows. The ...

Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CNTY-308 in B-cell ...

Flatiron Health, a healthtech company transforming clinical research through technology that integrates research into everyday care, today announced a collaboration with NRG Oncology (NRG), a clinical ...

Experts at the 2025 Clinical Trial Supply New England conference will discuss strategies for optimising clinical supply ...

Learn how the RB209 Nutrient Management Guide impacts nitrogen application in winter wheat trials at Terrington St Clement, Norfolk.

Preston-based clinical trials group, Panthera, has signed two clinical trial contracts worth more than £10m each. These trials for international pharma companies involve recruiting patients and ...